These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20666273)

  • 21. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.
    Famenini S; Sako EY; Wu JJ
    Am J Clin Dermatol; 2014 Feb; 15(1):45-50. PubMed ID: 24281789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
    Kaye JA; Li L; Jick SS
    Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study.
    Chiu HY; Chang WL; Huang WF; Wen YW; Tsai YW; Tsai TF
    J Am Acad Dermatol; 2015 Sep; 73(3):429-38. PubMed ID: 26188627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart disease in psoriasis.
    Kremers HM; McEvoy MT; Dann FJ; Gabriel SE
    J Am Acad Dermatol; 2007 Aug; 57(2):347-54. PubMed ID: 17433490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk and psoriasis: the role of biologic therapy.
    Puig L
    Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of psoriasis as independent predictor of cardiovascular disease: a meta-regression analysis.
    Gaeta M; Castelvecchio S; Ricci C; Pigatto P; Pellissero G; Cappato R
    Int J Cardiol; 2013 Oct; 168(3):2282-8. PubMed ID: 23490084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psoriasis: a systemic disease].
    Bens G; Maccari F; Estève E
    Presse Med; 2012 Apr; 41(4):338-48. PubMed ID: 22136910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease.
    Torres T; Sales R; Vasconcelos C; Martins da Silva B; Selores M
    J Dermatol; 2013 Nov; 40(11):923-6. PubMed ID: 24128349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The assessment and management of psoriasis.
    Jackson K
    Nurs Times; 2013 Jul 17-23; 109(28):18-9. PubMed ID: 23971318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis.
    Martyn-Simmons CL; Ranawaka RR; Chowienczyk P; Crook MA; Marber MS; Smith CH; Barker JN
    Br J Dermatol; 2011 Jan; 164(1):26-32. PubMed ID: 20819085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AJC editor's consensus: psoriasis and coronary artery disease.
    Friedewald VE; Cather JC; Gelfand JM; Gordon KB; Gibbons GH; Grundy SM; Jarratt MT; Krueger JG; Ridker PM; Stone N; Roberts WC
    Am J Cardiol; 2008 Dec; 102(12):1631-43. PubMed ID: 19064017
    [No Abstract]   [Full Text] [Related]  

  • 33. Normal endothelial function in patients with mild-to-moderate psoriasis: a case-control study.
    Jensen PR; Zachariae C; Hansen P; Skov L
    Acta Derm Venereol; 2011 Sep; 91(5):516-20. PubMed ID: 21547343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease.
    Yalcin H; Balci DD; Ucar E; Ozcelik N; Tasci C; Seyfeli E; Akgul F; Yalcin F
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):798-802. PubMed ID: 19470047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic nervous system dysfunction: a common pathway linking skin and heart morbidity?
    Mastrolonardo M
    J Am Acad Dermatol; 2008 Feb; 58(2):352. PubMed ID: 18222338
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis.
    Miller IM; Skaaby T; Ellervik C; Jemec GB
    Br J Dermatol; 2013 Dec; 169(6):1180-7. PubMed ID: 23815240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population.
    Irimie M; Oanţă A; Irimie CA; Fekete LG; Minea DI; Pascu A
    Acta Dermatovenerol Croat; 2015; 23(1):28-35. PubMed ID: 25969910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.